The development of a recombinant hepatitis E vaccine HEV 239.
about
Current Knowledge on Hepatitis EApproved Antiviral Drugs over the Past 50 YearsHepatitis E infection among Ghanaians: a systematic reviewImmunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.Viral hepatitis vaccination during pregnancyA preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regionsProphylaxis against hepatitis E: at risk populations and human vaccines.Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection.Preparation and evaluation of MS2 bacteriophage-like particles packaging hepatitis E virus RNA.Health economic evaluation of immunization strategies of hepatitis E vaccine for elderly population.Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid.Prophylactic Hepatitis E Vaccine.Escherichia coli-derived virus-like particles in vaccine development.Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.Hepatitis E: Update on Prevention and Control.Development of new hepatitis E vaccines
P2860
Q26782030-2F21C001-30DE-4F98-BFAE-ED7D7705CA75Q27755387-C81683E5-EBEB-4006-89E0-469FEC9AE664Q30238550-A544F4B1-F8E9-4D04-A4B5-E4A82D03B861Q36256455-DAFF8D6B-28DB-4878-95BB-2B43887BAEA6Q37130825-D48B75E2-3EB4-46B5-8EF3-4CF2111FEC07Q37197088-0E516547-D8D3-477B-BC58-D9B18C1BB9E5Q38699244-AEBCA67B-4D7A-48E1-8D54-17268E2F3ECFQ39025545-B7222F05-6AB6-4EFF-92A6-F1C090717972Q39355564-26F56BD0-D33C-490F-87D0-613EC75CC983Q40225311-29212F12-6513-41B2-ADA1-4FE0384C9E9BQ40231413-F3CD79C8-4838-48F7-9490-2A172A5ACC94Q40507392-A2A1D624-D3AA-485E-9700-B8F8516D580AQ47132009-5D5CDE46-0CC3-4898-84A8-70CA5AC1602DQ50058140-F1026EFC-E7BF-4D2B-8686-B630F040F286Q54254955-3277E69F-30F4-462E-9DF3-CDC76D5E5BB9Q56588500-25CBFA90-A077-4485-A188-F732A0937DA7
P2860
The development of a recombinant hepatitis E vaccine HEV 239.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The development of a recombinant hepatitis E vaccine HEV 239.
@ast
The development of a recombinant hepatitis E vaccine HEV 239.
@en
The development of a recombinant hepatitis E vaccine HEV 239.
@nl
type
label
The development of a recombinant hepatitis E vaccine HEV 239.
@ast
The development of a recombinant hepatitis E vaccine HEV 239.
@en
The development of a recombinant hepatitis E vaccine HEV 239.
@nl
prefLabel
The development of a recombinant hepatitis E vaccine HEV 239.
@ast
The development of a recombinant hepatitis E vaccine HEV 239.
@en
The development of a recombinant hepatitis E vaccine HEV 239.
@nl
P2093
P2860
P1476
The development of a recombinant hepatitis E vaccine HEV 239.
@en
P2093
Qinjian Zhao
Shao-Wei Li
P2860
P304
P356
10.1080/21645515.2015.1008870
P577
2015-01-01T00:00:00Z